首页 | 本学科首页   官方微博 | 高级检索  
     

细胞因子在造血干细胞移植中诱导免疫耐受的基础和应用研究
引用本文:常英军,黄晓军. 细胞因子在造血干细胞移植中诱导免疫耐受的基础和应用研究[J]. 北京大学学报(医学版), 2009, 41(2): 208-211. DOI: 10.3969/j.issn.1671-167X.2009.02.018
作者姓名:常英军  黄晓军
作者单位:(北京大学人民医院,北京大学血液病研究所, 北京100044)
基金项目:国家自然科学基金,国家教委跨世纪优秀人才计划基金,国家211工程学科建设项目,教育部高等学校博士学科点专项科研基金,卫生部科研基金,教育部教育振兴行动计划特殊专项(九工程) 
摘    要:血液恶性疾病是严重危害人类生命健康的重大疾病,异基因造血干细胞移植(allogeneic hemopoietic stem cell transplantation,Allo-HSCT)是绝大多数血液恶性疾病患者的有效乃至唯一的根治手段,Allo-HSCT的基础是异体植入及随后的移植物抗白血病(graft versus leukemia,GVL)效应,但Allo-HSCT同时发生移植物抗宿主病(graft versus host disease,GVHD),导致GVHD相关死亡.

关 键 词:细胞因子类  造血干细胞移植  免疫耐受  粒细胞集落刺激因子  

Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation
CHANG Ying-jun,HUANG Xiao-jun. Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation[J]. Journal of Peking University. Health sciences, 2009, 41(2): 208-211. DOI: 10.3969/j.issn.1671-167X.2009.02.018
Authors:CHANG Ying-jun  HUANG Xiao-jun
Affiliation:CHANG Ying-jun,HUANG Xiao-jun(Peking University People's Hospital & Peking University Institute of Hematology,Beijing 100044,China)
Abstract:Allo-HSCT is a potentially curative therapy for many hematological malignancies,the basis of which is graft-versus-leukemia(GVL) effect.However,acute graft-versus-host disease(GVHD) is responsible for 15% to 40% of mortality and is the major cause of morbidity after transplantation.Therefore,separation of GVHD and GVL partially or completely could improve the transplant outcomes.This study focuses on the effects of G-CSF on T cells in peripheral blood stem cell grafts and bone marrow grafts and its mechanis...
Keywords:Cytokines  Hematopoietic stem cell transplantation  Immune tolerance  Granulocyte colony-stimulating factor  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《北京大学学报(医学版)》浏览原始摘要信息
点击此处可从《北京大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号